LINC02757

Across TCGA pan-cancer cohorts, LINC02757 RNA differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of LINC02757’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where LINC02757 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC02757 is over-expressed in tumor, although a few such as LUAD and KICH show the opposite, repressed pattern.

LUAD, KICH, and LUSC are the cancer types where LINC02757 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02757 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	Female	All	−0.501	<.001	8	view →
KICH	Female	All	−0.609	<.001	7	view →
LUSC	Female	All	−0.677	<.001	6	view →
UCEC	All	All	−0.311	<.001	6	view →
BRCA	Female	All	−0.245	<.001	6	view →
KIRP	Male	All	−0.289	<.001	4	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

LINC02757–LUAD

Open the LUAD breakdown →